Eton Pharmaceuticals

ETON (NasdaqGM)

Eton Pharmaceuticals, Inc. is a Deer Park, Illinois-based company focused on developing and commercializing therapies for rare diseases. Its approved products include Increlex for severe primary IGF-1 deficiency, Alkindi Sprinkle for adrenal insufficiency, Khindivi for adrenocortical insufficiency, Galzin for Wilson disease, PKU Golike for phenylketonuria, Carglumic acid, Betaine Anhydrous, and Nitisinone. The company is advancing late-stage programs such as ET-600, Amglidia, ET-700, ET-800, and ZENEO for adrenal crises. Founded in 2017.